What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
Where is Wright Medical Group's stock going? Where will Wright Medical Group's stock price be in 2017?
14 equities research analysts have issued 1 year target prices for Wright Medical Group's shares. Their forecasts range from $22.00 to $33.00. On average, they expect Wright Medical Group's share price to reach $26.00 in the next twelve months.
When will Wright Medical Group announce their earnings?
Wright Medical Group is scheduled to release their next quarterly earnings announcement on Wednesday, May, 3rd 2017.
What are analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- Needham & Company LLC analysts commented, "WMGI's 4Q16 revenue and EBITDA beat consensus, and management provided initial 2017 revenue and EBITDA guidance that was above consensus. Pro forma revenue growth improved to 12% CC from 9% CC in 2Q16. As we had anticipated, management expects revenue growth to increase from 1H17 to 2H17 due to sales dis-synergies (which are lapped in 2H17), new product launches, and the sales force expansion. Also as we anticipated, EBITDA beat and management guided to above-consensus 2017 EBITDA. While this is clearly positive, we think it accelerates the point at which investors begin to value WMGI on an EV/EBITDA basis. If WMGI's EBITDA margin were to reach 20% in 2017, its EV/EBITDA would be 22.8x, which we think fairly values shares, and we maintain our Hold rating." (2/22/2017)
- Jefferies Group LLC analysts commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high watermark; and guidance for mid-teens underlying revenue growth supported by numerous product launches. Wright remains exceedingly well positioned and it remains one of our best ideas." (2/22/2017)
- BMO Capital Markets analysts commented, "WMGI reported revenue of $193M (up 16%; up 12% adjusted), nicely ahead of the Street's $183.4 million, including: Lower Extremities up 7% adjusted; Upper Extremities up 15%; Biologics up 28%; and Sports Medicine up 5%. With the integration of Tornier largely in the rear-view mirror, adjusted EBITDA increased meaningfully to $22.7 million from $9.3 million y/y, as management is benefiting from cost synergies that were obtained earlier than expected and better-than-expected revenue. Combined, the result was non-GAAP EPS loss of $0.06 versus the Street's loss of $0.11." (2/22/2017)
According to Zacks Investment Research, "Wright Medical's second-quarter results impressed us. Although the company continued to incur loss, the figure narrowed from the year-ago quarter. The company also raised revenue and EBITDA guidance for full-year 2016. We believe that post merger with Tornier, Wright Medical will have significant growth prospects in both the upper and lower extremities markets, two of the fastest growing segments of the orthopaedics industry. Moreover, Augment Bone Graft product will drive growth in the biologics business going forward. However, escalating infrastructure cost remains a major headwind. Moreover, the anticipated dis-synergies in the lower extremities segment will impact top-line growth in the near term. Although management expects the impact to be limited, we believe the dis-synergy concern will be an overhang on the stock for the rest of this year." (8/10/2016)
Who owns Wright Medical Group stock?
Wright Medical Group's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include FMR LLC (15.03%), Orbimed Advisors LLC (7.36%), Janus Capital Management LLC (3.21%), Palo Alto Investors LLC (2.53%), Loomis Sayles & Co. L P (1.24%) and Foundation Asset Management LP (0.94%). Company insiders that own Wright Medical Group stock include David H Mowry, Elizabeth H Weatherman, Julie Andrews, Julie D Tracy, Kevin D Cordell, Lance A Berry, Pascal E R Girin, Patrick Fisher, Richard F Wallman, Sean Carney, Stephan Epinette, William L Griffin Jr and William L Griffin, Jr.
Who sold Wright Medical Group stock? Who is selling Wright Medical Group stock?
Wright Medical Group's stock was sold by a variety of institutional investors in the last quarter, including Folger Hill Asset Management LP, Federated Investors Inc. PA, Janus Capital Management LLC, Dimensional Fund Advisors LP, Bayesian Capital Management LP and Envestnet Asset Management Inc.. Company insiders that have sold Wright Medical Group stock in the last year include David H Mowry, Elizabeth H Weatherman, Julie Andrews, Kevin D Cordell, Lance A Berry, Patrick Fisher, Richard F Wallman, Sean Carney and William L Griffin Jr.
Who bought Wright Medical Group stock? Who is buying Wright Medical Group stock?
Wright Medical Group's stock was purchased by a variety of institutional investors in the last quarter, including Foundation Asset Management LP, Orbimed Advisors LLC, Palo Alto Investors LLC, Loomis Sayles & Co. L P, Thrivent Financial for Lutherans, FMR LLC, Russell Investments Group Ltd. and Teachers Retirement System of The State of Kentucky.
How do I buy Wright Medical Group stock?
Shares of Wright Medical Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Wright Medical Group stock cost?
One share of Wright Medical Group stock can currently be purchased for approximately $27.96.